Skip to navigation Skip to content



Bladder Medication Boosts Myelin Repair in Mice, Report Researchers Funded by National MS Society

March 2, 2015

Researchers at the University of Buffalo funded by the National MS Society show that a medication approved by the FDA to treat overactive bladder stimulates myelin repair in mice. Administering the medication blocked a molecule that prevents myelin-making cells from developing. Blocking this molecule led to improvements in myelin formation and nerve impulse conduction.

Read more about this research on the University of Buffalo News Center
Read more about research to repair MS damage

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.